European Journal of Medicinal Chemistry p. 455 - 464 (2019)
Update date:2022-07-29
Topics:
Winters, Maria
DuHadaway, James B.
Pham, Khoa N.
Lewis-Ballester, Ariel
Badir, Shorouk
Wai, Jenny
Sheikh, Eesha
Yeh, Syun-Ru
Prendergast, George C.
Muller, Alexander J.
Malachowski, William P.
Tryptophan (Trp) catabolizing enzymes play an important and complex role in the development of cancer. Significant evidence implicates them in a range of inflammatory and immunosuppressive activities. Whereas inhibitors of indoleamine 2,3-dioxygenase-1 (IDO1) have been reported and analyzed in the clinic, fewer inhibitors have been described for tryptophan dioxygenase (TDO) and indoleamine 2,3-dioxygenase-2 (IDO2) which also have been implicated more recently in cancer, inflammation and immune control. Consequently the development of dual or pan inhibitors of these Trp catabolizing enzymes may represent a therapeutically important area of research. This is the first report to describe the development of dual and pan inhibitors of IDO1, TDO and IDO2.
View MoreHebei DaPeng Pharm & Chem Co., Ltd.
Contact:86-317-7298678,0576-88861898 88861908
Address:West Songmen Village, East Songmen Town, Wuqiao, Cangzhou, Hebei ,China
Wuxi Zuping Food Science And Technology Co.,LTD.
Contact:+86-510-87210822
Address:Guanlin town
Triumph International Development Limilted
website:http://www.jiashengchem.cn/
Contact:+86-536-7971999
Address:Yinhai Road,Shouguang
Ningbo Hi-tech Zone Nice-Synth Chemical Industry Ltd.
Contact:+86-(574)-81110986
Address:No. 1210, Building 3, Wante Business Centre, Hi-tech Zone, Ningbo
Shanggao Ruiya Fine Chemicals Co., Ltd
Contact:+86-795-2592103
Address:Xingguang Nanlu,Shanggao County Industry Park
Doi:10.1021/ol900779v
(2009)Doi:10.1016/0008-6215(87)85004-8
(1987)Doi:10.1016/j.jorganchem.2008.09.059
(2009)Doi:10.1002/jhet.5570390104
(1898)Doi:10.1021/acs.orglett.9b01192
(2019)Doi:10.1016/S0040-4039(00)96366-4
(1987)